Ilimumab: long-term follow-up of 177 individuals with metastatic melanoma. Clin Cancer Res
Ilimumab: long-term follow-up of 177 individuals with metastatic melanoma. Clin Cancer Res Off J Am Assoc Cancer Res 2012, 18:2039-2047. 14. Gridelli C, De Marinis F, Di Maio M, Cortinovis…